Abstract| Volume 23, ISSUE 10, SUPPLEMENT , S83, October 2017

A Case of Peripartum Cardiomyopathy Treated by Anti-Prolactin Therapy

      Peripartum cardiomyopathy, heart failure develops in the women without history of heart disorder, in an echocardiography, shows cardiomegaly and reduced LVEF, there is the case leading to maternal death. Our case was a 29 year-old pregnant woman without any history of heart failure. This was her first pregnancy and delivery. On 29th pregnancy week, she underwent fetoscopic laser surgery for twin-twin transfusion syndrome. She was hospitalized by threatened premature delivery on 35th pregnancy week. On 5th hospital day, she suddenly developed dyspnea and desaturated. Chest X ray detected cardiomegaly with severe pulmonary edema. She was diagnosed with acute heart failure and underwent an urgent cesarean section, by which the baby was delivered alive. However, during the operation, cardiopulmonary resuscitation was performed as she suffered cardiopulmonary arrest. In ICU, blood test showed BNP 626.8 pg/mL and TnI 184 ng/mL. UCG detected diffuse severe LV hypokinesis (LVEF 20%). After ROSC was confirmed with stable hemodynamic condition, TTM was conducted. We used an anti-prolactin agent in combination with standard heart failure therapy and LVEF was gradually improved. She left an ICU on 8th hospital day with symptom free from heart failure and without any neurological sequelae.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Cardiac Failure
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect